| Literature DB >> 35636279 |
Yang Liu1, Yuning Wang1, Zhuonan Pu1, Yuchao Wang1, Yixin Zhang1, Chuankun Dong1, Yan Zeng1, Shu Zhou2.
Abstract
BACKGROUND: According to previous studies of male infertility, we found that the association between sexual dysfunction and male infertility was reported rarely and controversially. AIM: We carried out this 1meta-analysis to evaluate the prevalence of sexual dysfunction and the International Index of Erectile Function (IIEF) score in infertile men.Entities:
Keywords: Infertility; International Index of Erectile Function; Men; Sexual Dysfunction
Year: 2022 PMID: 35636279 PMCID: PMC9386642 DOI: 10.1016/j.esxm.2022.100528
Source DB: PubMed Journal: Sex Med ISSN: 2050-1161 Impact factor: 2.523
Figure 1Flow diagram.
Characteristics of the controlled studies on sexual dysfunction in infertile and fertile men in the systematic review
| Author | Country | Study design | Quality score | Conflict of interest | Ethics committee approval | Infertility Diagnostic | Sample size,number | Age | Erectile dysfunction prevalence | P | IIEF-5(0-25) | P | IIEF-15 | P | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infertile | Fertile | Infertile | Fertile | Infertile | Fertile | Infertile | Fertile | Infertile | Fertile | ||||||||||
| Kızılay et al. (2017) | Turkey | Cross-sectional | 5 | No | Yes | Male infertility | 98 | 81 | 33.75 ± 3.46 | 34.99 ± 3.46 | |||||||||
| Ozkan et al. (2015) | Turkey | Case-control | 8 | No | Yes | Male infertility | 56 | 48 | 33.9 ± 5.1 | 35.6 ± 3.7 | 84.9% | 100% | >0.05 | 45.7 ± 7.5 | 50.4 ± 3.2 | ||||
| Gao et al. (2013) | China | Cross-sectional | 10 | No | Yes | Male infertility | 1468 | 942 | 28.47 ± 6.29 | 27.92 ± 7.03 | 18.05% | 8.28% | 0.001 | 21.24 ± 6.17 | 23.28 ± 4.25 | 0.012 | |||
| Drosdzol et al. (2008) | Poland | Cross-sectional | 7 | No | Yes | Infertile couples | 188 | 190 | 31.4 ± 4.7 | 32.8 ± 6.5 | 23.9% | 13.7% | 66.5 ± 8.9 | 68.4 ± 5.7 | |||||
| Lotti et al. (2016) | Italy | Cross-sectional | 7 | No | Yes | Male infertility | 448 | 74 | 36.8 ± 7.9 | 36.2 ± 5.0 | 18.3% | 0% | 0.006 | ||||||
| Pan et al. (2013) | China | Cross-sectional | 7 | No | Yes | Infertile couples | 245 | 52 | 31 ± 4.1 | 50.61% | 15.38% | <0.01 | 21.24 ± 2.58 | 23.21 ± 1.61 | |||||
| Ma et al. (2017) | China | Cross-sectional | 6 | No | Yes | Male infertility | 245 | 97 | 33.1 ± 4.9 | 33.0 ± 5.1 | 28.6% | 12.4% | 0.002 | 21.4 ± 3.9 | 23.2 ± 3.1 | 0.001 | |||
| Marci et al. (2012) | Italy | Case-control | 7 | No | Yes | Infertile couples | 30 | 52 | 38.53 ± 2.87 | 37.30 ± 3.45 | 26.6% | 0% | |||||||
| Monga et al. (2004) | U.S. | Cross-sectional | 5 | No | Yes | Infertile couples | 18 | 12 | 35 ± 4.25 | ||||||||||
| Canyan et al. (2015) | Turkey | Cross-sectional | 5 | No | Yes | Male infertility | 563 | 100 | 32.55 ± 6.12 | 32.34 ± 6.77 | 42.7% | 28% | |||||||
IIEF = International Index of Erectile Function.
The Agency for Healthcare Research and Quality was used for quality scoring in the included studies.
The Newcastle Ottawa Scale was used for quality scoring in the included studies.
Characteristics of the noncontrolled studies on sexual dysfunction in infertile men included in the systematic review
| Author | Country | Study design | Conflictof interest | Ethicscommittee approval | Infertility Diagnostic | Patients number | Age | Erectile dysfunction prevalence | IIEF-5(0-25) | IIEF-15 |
|---|---|---|---|---|---|---|---|---|---|---|
| Mazzilli et al. (2020) | Italy | cross-sectional | No | Yes | male infertility | 3280 | NA | |||
| Yıkılmaz TN et al. (2019) | Turkey | cross-sectional | No | Yes | infertile men with non-obstructive azoospermia | 193 | 31 ± 4.2 | 35.2% | 16 | |
| Lotti et al. (2012) | Italy | cross-sectional | No | Yes | Couple Infertility | 244 | 35.2 ± 7.8 | 17.8% | ||
| Song et al. (2016) | Korea | cross-sectional | No | Yes | male partners of infertile couples | 236 | 38.5 | 51% | ||
| Khademi et al. (2008) | Iran | cross-sectional | No | Yes | Infertile Couples | 100 | 32.3 ± 5.3 | 61.6% | ||
| Shindel et al. (2008) | America | cross-sectional | No | Yes | Infertile Couples | 121 | 35 ± 7 | 22% | 65.9 ± 10.1 | |
| Pasha et al. (2020) | Iran | cross-sectional | No | Yes | Infertile Couples | 204 | 31.77 ± 5.47 | 58.30 ± 8.52 | ||
| Yang et al. (2018) | China | cross-sectional | No | Yes | Infertile Couples | 4299 | 32.85 ± 5.98 | 57.8% | ||
| Ma et al. (2021) | China | cross-sectional | No | Yes | Infertile Couples | 387 | 33.9 ± 5.7 | 33.3% | 21.2 ± 3.9 | |
| Coward et al. (2019) | America | cohort | No | Yes | Infertile Couples | 708 | 34.2 ± 5.6 | |||
| 2Shindel et al. (2008) | America | cross-sectional | No | Yes | Infertile Couples | 73 | 34 ± 7 | 68.1 ± 7.3 |
IIEF = International Index of Erectile Function.
Figure 2Results of the meta-analysis for the prevalence of sexual dysfunction.
Figure 3Results of the meta-analysis for total IIEF score controlled studies.
Figure 4Results of the meta-analysis for erectile function.
Figure 5Results of the meta-analysis for orgasm.
Figure 6Results of the meta-analysis for sexual desire.
Figure 7The sensitivity analysis on erectile function.
Figure 8Results of the meta-analysis for intercourse satisfaction.
Figure 9Results of the meta-analysis for overall satisfaction.
Figure 10The sensitivity analysis on the prevalence of sexual dysfunction.
Figure 11Funnel plot of the controlled studies.
The quality of included case-control studies performed using NOS
| Study | Selection | Comparability control for important factor | Exposure | Scores | |||||
|---|---|---|---|---|---|---|---|---|---|
| Adequate definition of cases | Representativeness of the cases | Selection of controls | Definition of controls | Ascertainment of exposure | Same method of ascertainment for cases and controls | Nonresponse rate | |||
| Ozkan et al.(2015) | ☆ | ☆ | ☆ | ☆ | ☆☆ | ☆ | ☆ | 8 | |
| Marci et al.(2012) | ☆ | ☆ | ☆ | ☆ | ☆ | ☆ | ☆ | 7 | |
The quality of included cross-section studies performed using AHRQ
| Kızılay et al. (2017) | Gao et al. (2013) | Drosdzol et al. (2008) | Lotti et al. (2016) | Pan et al. (2013) | Ma et al. (2017) | Monga et al. (2004) | Canyan et al. (2015) | |
|---|---|---|---|---|---|---|---|---|
| Define the source of information | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Indicate time period used for identifying patients | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| Indicate whether or not subjects were consecutive if not population-based | No | Yes | No | Unclear | No | No | No | Unclear |
| Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants | No | No | NO | No | No | No | No | Unclear |
| Describe any assessments undertaken for quality assurance purposes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Explain any patient exclusions from analysis | No | Yes | Yes | Yes | Yes | No | No | Unclear |
| Describe how confounding was assessed and/or controlled | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| If applicated, explain how missing data were handled in the analysis | Unclear | Yes | Unclear | Unclear | Unclear | Unclear | Unclear | Unclear |
| Summarize patient response rates and completeness of data collection | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Unclear |
| Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained | Unclear | Yes | Unclear | No | No | No | No | Unclear |
| 5 | 10 | 7 | 7 | 7 | 6 | 5 | 5 |